Comparison Chart Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.220 USD | -1.50% |
|
+3.14% | -18.14% |
| 04-09 | Vanda Asks FDA to Withdraw Proposal Extending Drug Review Timelines | MT |
| 04-08 | Vanda Pharmaceuticals Starts Study of Nereus to Address GLP-1 Side Effects | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Bio Therapeutic Drugs | -1.50% | +3.14% | -18.14% | +76.96% | -55.57% | 427M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition